Search results

Order by most recent / most popular / relevance

Results: 1-10 of 280

Interesting consumer protection twist

Reed Smith LLP
-
USA
-
May 10 2013

Every now and then we come across something new and interesting that, frankly, we hadn't thought of ourselves. That's how we felt when we read the

Big sky beat down

Reed Smith LLP
-
USA
-
May 9 2013

We read rulings under the Federal Tort Claim Act about as often as we read bench trial rulings or rulings from the District of Montana. Or rulings

Pennsylvania courts struggle with insurance coverage for defective product claims

Reed Smith LLP
-
USA
-
January 28 2013

In 2012, Judge Wettick of the Allegheny County Court of Common Pleas issued two decisions that have the potential to significantly limit the

Restricting cross-jurisdictional class action tolling - backwards

Reed Smith LLP
-
USA
-
December 6 2012

Anybody who follows this blog at all closely knows that we hate cross-jurisdictional class action tolling

Just how "illegal" is off-label promotion?

Reed Smith LLP
-
USA
-
February 15 2013

Until recently it's simply been accepted that the FDA administratively banned off-label promotion - no ifs, ands, or buts. Bexis' book used to read:

A one-two punch in the ArediaZometa litigation

Reed Smith LLP
-
USA
-
February 22 2013

Novartis scored a double victory in the Northern District of California last week, when the court granted a Daubert motion to preclude Plaintiff's

An analysis of the Consumer Product Safety Improvement Act of 2008

Reed Smith LLP
-
USA
-
August 19 2008

The Act is particularly relevant as it covers, includes or updates: the ban on the use of lead in children’s products, and mandatory third-party testing of imported children’s products; restrictions on phthalates in children’s toys and child care articles; greater access for the public to information trolled by plaintiff’s lawyers; all-terrain vehicle standards; and increased resources for the testing and inspection of products, including those coming into our nation’s ports

FDA proposes changes to Orphan Drug Regulations

Reed Smith LLP
-
USA
-
October 21 2011

On October 19, 2011 the Food and Drug Administration published a proposed rule in the Federal Register that would amend the 1992 Orphan Drug Regulations issued to implement the Orphan Drug Act